Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Shreveport-Bossier City, LA MSA — October 2026
Shreveport pay diverges sharply by life sci role this month.
Validation Engineer pay in Shreveport hit $172,800 against a stable national median of $106,478, while Regulatory Affairs pay fell significantly locally even as national demand for the role stays acute.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Validation Engineer metro pay: $172,800 — vs $106,478 national median, stable
- Regulatory Affairs metro pay: -significant — National pay also down moderate despite hiring scarcity
- LA pharma manufacturing employment: -2.4% — Annual change 2021-2026, QCEW
- Shreveport metro weekly earnings: $997.58 — September 2026, up from prior year
Key takeaways
Validation Engineer pay in Shreveport has outpaced the nation.
Metro median of $172,800 compares to a stable national median of $106,478, pointing to acute local scarcity concentrated in this metro. Organizations building or expanding manufacturing-adjacent functions in this metro should expect to pay a substantial premium over national postings for this credential.
Regulatory Affairs pay is falling against a tightening national market.
Metro advertised pay dropped significantly while national demand for regulatory talent is described as the hardest to fill in 2026. Declining local pay in a nationally scarce role may suggest fewer active regulatory searches locally, a pattern distinct from a loosening market, and warrants a closer look before setting offers.
Clinical Research Associate pay is rising faster locally than nationally.
Metro median CRA pay ($95,455, up significant) now exceeds the national median ($90,065, also up significant), consistent with national commentary that experienced CRAs remain the primary bottleneck. Build-vs-outsource calculus with CROs should account for this metro now commanding a premium on CRA talent.
State pharma manufacturing contraction narrows the local talent pool.
Brand-name pharmaceutical manufacturing employment in Louisiana fell 2.4% annually even as AstraZeneca and Sanofi maintain facilities in-state. Shrinking in-state manufacturing headcount capacity may push Life Sci leaders toward CDMO partnerships for production-scale roles over organic hiring.
Median advertised pay by role — Shreveport-Bossier City, LA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $68,562 | $117,568 | $143,357 | Stable | $130,339 |
| Clinical Research Associate * | $69,943 | $95,455 | $100,011 | Significant increase | $90,065 |
| Lab Technician * | $40,560 | $47,244 | $65,795 | Moderate increase | $47,840 |
| Regulatory Affairs Specialist * | $71,414 | $96,238 | $116,373 | Significant decline | $103,780 |
| Clinical Data Manager * | $96,750 | $127,578 | $150,000 | Stable | $123,653 |
| Biostatistician * | $109,878 | $128,135 | $152,000 | Stable | $131,958 |
| Validation Engineer * | $97,703 | $172,800 | $172,800 | Significant increase | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Shreveport-Bossier's 171,700 nonfarm payroll base remains tight at the specialized end even as construction (+12.4% YoY) and manufacturing (+5.1% YoY) absorb available technical and skilled-trades labor, competing directly with life sciences employers for engineers and quality personnel. Statewide, pharmaceutical manufacturing payrolls continue to contract (-2.4% annually), while average weekly earnings in Shreveport rose to $997.58, signaling that pay pressure is building even in a metro with limited dedicated biotech infrastructure.
What it means
Metro-level Validation Engineer pay has jumped sharply (national median stable at $106,478 versus metro's $172,800), a signal that Shreveport employers may be bidding up scarce engineering talent against construction and manufacturing demand, competition that reflects a shallow local biotech labor pool. Regulatory Affairs Specialist pay has fallen both locally (-significant) and nationally (-moderate), which appears inconsistent with national reports of regulatory talent as the hardest role to fill — a divergence worth investigating before assuming local compensation has kept pace with skill scarcity. Consider reviewing whether Shreveport-based regulatory and quality roles are being benchmarked against the right comparison set, given the state's declining brand-name pharma manufacturing footprint and limited local competitive density.
Looking ahead
Worth watching: Construction and manufacturing payroll growth in Shreveport-Bossier is drawing skilled engineering and technical talent away from adjacent sectors. Watch whether Validation Engineer and bioprocess-adjacent pay continues climbing as local competition for credentialed talent intensifies.
Emerging pressure point: Regulatory Affairs advertised pay has declined locally and nationally even as employers report the role as the hardest to fill. Track whether this reflects fewer active local postings or an easing of urgency before adjusting offer strategy.
Potential inflection point: Statewide pharmaceutical manufacturing employment continues contracting annually. A further decline could accelerate CDMO/CRO outsourcing conversations for Shreveport-based production and quality functions.
Early indicator: National quit rate sits at just 1.9% even as 64% of biopharma organizations report active recruiting. Watch for whether Shreveport-area specialized scientific and regulatory staff begin moving in greater numbers as national hiring momentum builds, or whether low mobility persists.
Sources
- BIZ Magazine / U.S. Bureau of Labor Statistics — Shreveport-Bossier nonfarm payrolls and sector growth rates
- Bureau of Labor Statistics QCEW — Louisiana brand-name pharmaceutical manufacturing employment decline
- Industry workforce survey (pre-researched national context) — Regulatory affairs cited as hardest pharma role to fill nationally in 2026
- Industry workforce survey (pre-researched national context) — CRA talent remains the experienced-hire bottleneck nationally
- U.S. Bureau of Labor Statistics — Shreveport average weekly earnings reached $997.58 in September 2026
- Industry workforce survey (pre-researched national context) — National quit rate at 1.9% amid active biopharma recruiting
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.